|
Dr. Pinedo has over thirty years of extensive oncology experience in medical practice and research and he continues to be a thought leader to both the medical and research communities. Dr. Pinedo is currently Professor of Medical Oncology at the Vrije University Medical Center (VUmc) and former director of the VUmc Cancer Center Amsterdam (VUmc CCA).
Dr. Pinedo�s work focuses on translational research, in particular, drug resistance, angiogenesis and immunology. He is a member of the British Royal Society of Medicine and The Royal Dutch Academy of Science and Arts, where he is Chairman of the Board of the Medical Division. Dr. Pinedo founded the New Drug Development Office (NDDO) - Oncology, which coordinates early clinical trials with anticancer agents internationally. He was the first President of the Federation of European Cancer Societies (FECS), and Past President to the European Society of Medical Oncology (ESMO). Dr. Pinedo is the co-founder of the Annals of Oncology and The Oncologist and is the Co-Editor of Current Opinion in Anticancer Drugs. He serves on numerous editorial boards including Clinical Cancer Research, and Journal of Clinical Oncology. Dr. Pinedo has authored more than 600 peer-reviewed international publications and more than 120 chapters, invited papers or proceedings. Dr. Pinedo has received many international awards including the prestigious Josef Steiner award and has been decorated by H.M. Queen Beatrice of the Netherlands with the prestigious Knight of the Order of the Netherlands Lion. | 